MLTX
Closed
Moonlake Immunotherapeutics
46.61
-0.59 (-1.25%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 47.2
Day's Range: 46.24 - 47.93
Send
sign up or login to leave a comment!
When Written:
21.08
I'm sorry, as an AI language model, I do not have access to current information about MoonLake Immunotherapeutics as it is subject to change over time. However, MoonLake Immunotherapeutics is a biotechnology company that focuses on developing immunotherapies for the treatment of cancer and autoimmune diseases. Their approach involves using synthetic biology to engineer T-cells to recognize and attack cancer cells or to suppress the immune response in autoimmune diseases. They are currently in the pre-clinical stage of development and have not yet brought any products to market.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








